Recent News

• 10.27.2026 - NEXGEL Regains Compliance with Nasdaq Listing Requirement
• 10.12.2026 - NEXGEL Announces 1-for-20 Reverse Stock Split Effectiveness
• 09.23.2026 - NEXGEL Announces Dial-In Details for Investor Update Call
• 09.16.2026 - NEXGEL Announces Date for Investor Update Call
• 08.20.2026 - NEXGEL ANNOUNCES LEADERSHIP TRANSITION AND STRATEGIC REVIEW INITIATIVE
• 08.17.2026 - NEXGEL Reports Second Quarter 2026 Financial Results
• 06.04.2026 - NEXGEL to Present at Planet MicroCap Conference Las Vegas on June 16th –18th
• 05.19.2026 - NEXGEL Reports Positive Data from Randomized Single-Center IRB Study to Evaluate the Effectiveness and Safety of a Hydrogel Laser Treatment Patch in Laser Hair Removal with a 95.6% Reduction in Plume Concentration
• 05.13.2026 - NEXGEL Appoints Dave Hazard as Vice President of Sales for BIONX Surgical
• 05.12.2026 - NEXGEL To Report First Quarter 2026 Financial Results on May 15th

Recent Filings

• 10.07.2026 - 8-K Current report
• 09.30.2026 - 144 Report of proposed sale of securities
• 09.24.2026 - 8-K Current report
• 09.24.2026 - EX-99.1 EX-99.1
• 09.23.2026 - 8-K Current report
• 08.24.2026 - DEF 14A Other definitive proxy statements
• 08.21.2026 - 8-K Current report
• 08.21.2026 - EX-99.1 EX-99.1
• 08.20.2026 - S-1 General form for registration of securities under the Securities Act of 1933
• 08.17.2026 - 8-K Current report